Description: Key Insights The projected fair value for Thermo Fisher Scientific is US$603 based on 2 Stage Free Cash Flow to Equity...

Description: The North America Mass Spectrometry Market is poised to surge from US$ 2.6 Billion in 2024 to US$ 4.87 Billion by 2033, driven by a 7.21% CAGR. Key growth areas include pharmaceutical, environmental analysis, and food safety sectors, powered by advancements in mass spectrometry technology enhancing sensitivity and precision. Major drivers include increased demand in the pharmaceutical and biotechnology sectors, advancements in hybrid and high-resolution technologies, and growing applications in

Description: The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological advancements, increased awareness, and supportive government initiatives. Rapid point-of-care tests and molecular diagnostics are gaining traction, while high costs and regulatory hurdles persist as challenges. Major markets like California, Texas, New York, and Florida lead

Description: Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

Description: Ever wondered if Thermo Fisher Scientific's stock is truly worth its current price? Let's dive into what those numbers may be telling us. The share price has climbed an impressive 14.4% over the past year, with a 12.2% gain so far in 2024. This signals growing investor confidence and possible changes in how the market perceives the company's risks and rewards. Recently, Thermo Fisher has been in the spotlight after expanding partnerships with major pharmaceutical players and making...

Description: WALTHAM, Mass., November 25, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €2.1 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary:

Description: Net Lease Office Properties (NYSE: NLOP) reported today that its Board of Trustees declared a special cash distribution of $4.10 per common share, totaling approximately $60.7 million. The distribution is payable on December 19, 2025 to shareholders of record as of the close of business on December 4, 2025.

Description: The Liquid Biopsy market is projected to grow robustly from US$ 4.29 Billion in 2024 to US$ 15.46 Billion by 2033, driven by advancements in oncology and precision medicine. This sector benefits from the minimally invasive nature of liquid biopsies, which allow early cancer detection and treatment monitoring through blood samples. Key players like Roche, Exact Sciences, and Thermo Fisher are enhancing their offerings to meet the rising demand. Innovations and regulatory approvals continue to exp

Description: GS stands out as Zacks showcases how its stock picks like MU and PRLD delivered strong gains despite a shaky market.

Description: While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Description: Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

Description: BILLERICA, Mass., November 20, 2025--Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company’s next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company’s Board

Description: CARLSBAD, Calif., November 20, 2025--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors w

Description: Thermo Fisher's new all-in-one SureTect qPCR assay promises faster, broader beverage spoilage detection and sharper quality control.

Description: OutSystems, the leading AI-powered low-code development platform, today announced strong early momentum for Agent Workbench, its enterprise-grade platform for building and orchestrating intelligent AI agents across data sets, workflows, or systems. Following its general availability launch on September 30, enterprises across industries are already using Agent Workbench to accelerate agentic transformation, moving from pilots to production and orchestrating multi-agent workflows with built-in hum

Description: Thermo Fisher Scientific recently received U.S. 510(k) clearance for its EXENT System, an automated analyser aimed at improving the diagnosis of multiple myeloma, and announced the grand opening of its East Coast Advanced Therapies Collaboration Center in Philadelphia to support cell and gene therapy innovation. These milestones expand Thermo Fisher's expertise in diagnostics and advanced therapies, providing researchers and clinicians with new tools and infrastructure to accelerate...

Description: MIAMI, November 19, 2025--OutSystems, the leading AI-powered low-code development platform, today announced strong early momentum for Agent Workbench, its enterprise-grade platform for building and orchestrating intelligent AI agents across data sets, workflows, or systems. Following its general availability launch on September 30, enterprises across industries are already using Agent Workbench to accelerate agentic transformation, moving from pilots to production and orchestrating multi-agent w

Description: WALTHAM, Mass., November 19, 2025--To support the quality of beverage products, Thermo Fisher Scientific today introduced the Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay**, an industry-first all-in-one quantitative Polymerase Chain Reaction (PCR)-based test developed in collaboration with Coca-Cola Europacific Partners. Now part of the Thermo Scientific SureTect PCR System, the assay offers early and accurate detection of spoilage organisms earlier in the production proce

Description: Amanda Murphy, senior director at GlobalData shares how companies can ensure success amidst consolidation in the clinical services sector.

Description: WALTHAM, Mass., November 17, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (MG) Registry. This nationwide registry will collect data from MG patients across the United States to study and evaluate existing and emerging MG therapies, tracking health conditions, safety issues, medication usage and overall treatment effectiveness. By leveraging real-world data, the registry w

Description: Zacks spotlights NVIDIA, Micron and Thermo Fisher in its latest Analyst Blog, highlighting AI-driven tailwinds, memory-market momentum and ongoing innovation across life sciences.

Description: Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Description: Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound healing, tissue engineering, and cosmetics. Notable firms include Thermo Fisher and Merck.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. Recombinant human fibrobla

Description: Thermo Fisher presents market opportunities through digital transformation, innovation programs, and strategic tech initiatives. They leverage partnerships, product launches, and acquisitions across segments like Life Sciences, Analytical Instruments, and Diagnostics, aiding pharmaceuticals, research, and healthcare sectors.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025" company profile has been added to ResearchAndMarkets.com's o

Description: Thermo Fisher Scientific (TMO) has caught investors’ attention lately as its shares climbed more than 10% over the past month. The company’s strong recent momentum has some market watchers reassessing its long-term prospects. See our latest analysis for Thermo Fisher Scientific. After a period of sluggishness earlier this year, Thermo Fisher Scientific's 10% share price surge over the past month stands out. This supports a positive year-to-date gain and helps lift its one-year total...

Description: NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.

Description: HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.

Description: Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Description: Devyser Diagnostics AB (FRA:OL0) reports a 20% sales growth and strong cash position, while navigating distributor sales decline and profitability hurdles.

Description: STAMFORD, Conn., November 12, 2025--Enterprise leaders will join the ISG AI Impact Summit, November 17–18 in New York, to discuss adopting, scaling and governing AI business solutions.

Description: WALTHAM, Mass., November 12, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind automated platform for clinical laboratories. The EXENT System combines enhanced sensitivity and automation to provide accurate results, helping clinicians make a fast diagnosis for patients with multiple myeloma and related disorders.

Description: Investors need to pay close attention to TMO stock based on the movements in the options market lately.

Description: Amgen, Ciena, and Fair Isaac shine as Zacks' proven stock-ranking strategies continue to outperform amid market uncertainty.

Description: The life sciences giant signals confidence with a massive repurchase plan and steady shareholder payouts

Description: Thermo Fisher Scientific (NYSE:TMO) has had a great run on the share market with its stock up by a significant 23% over...

Description: WALTHAM, Mass., November 06, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.

Description: WALTHAM, Mass., November 06, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on January 15, 2026, to shareholders of record as of December 15, 2025.

Description: Diamond Hill Capital, an investment management company, released its “Large Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets continued their YTD rally in the third quarter of 2025, with the Russell 3000 Index gaining 8%, bringing the calendar-year returns to over 14%. The portfolio declined and underperformed the […]

Description: Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for diagnostics in developing regions, growing integration into sequencing platforms, gene-editing advancements, and expanding applications in personalized medicine and agricultural biotechnology. Cas12 Protein Market Cas12 Protein Market Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Cas12 Protein Market Report 2025" has been added to ResearchAndMarkets.com's offering. The Cas12 Protei

Description: The global methyl acetate market is projected to grow from USD 228.0 million in 2025 to USD 388.5 million by 2030, at a CAGR of 7.9%. This growth is driven by its fast-evaporating, low-toxicity advantages, making it a preferred solvent in paints, coatings, adhesives, pharmaceuticals, and electronics. With increasing VOC regulations from environmental bodies like the EPA and ECHA, manufacturers are innovating by offering sustainable, high-purity variants. Asia Pacific leads the market, supported

Description: Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]

Description: Low-cost index funds make it easy to achieve average market returns. But in any diversified portfolio of stocks, you'll...

Description: Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. Gar

Description: Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index decreasing 0

Description: Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index easing 0.1% and t

Description: The completion of the acquisition is anticipated by mid-2026, pending the satisfaction of customary closing conditions.

Description: Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Description: If you are watching Thermo Fisher Scientific right now and wondering what your next move should be, you are not alone. This stock has been on quite a journey lately, making it a hot topic for investors seeking growth or reassessing risk. Over the past month, Thermo Fisher shares have surged 20.1%, a noticeable rally that follows a steadier 6.7% gain year-to-date and a modestly positive 2.2% return over the past year. Recently, there has been increased investor confidence, partly sparked by...

Description: The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.

Description: Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.

Description: WALTHAM, Mass., October 29, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.

Description: Thermo Fisher's third quarter results drew a positive market response, with management attributing outperformance to robust momentum in bioproduction, analytical instruments, and clinical research businesses. CEO Marc Casper highlighted the successful integration of recent acquisitions and an active capital deployment strategy as core contributors. The company also benefited from operational execution and productivity improvements, particularly through its Practical Process Improvement (PPI) bus

Description: [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Airport Cabin Baggage Scanner Market size & share revenue was valued at approximately USD 3.2 Billion in 2024 and is expected to reach USD 3.5 Billion in 2025 and is expected to reach around USD 7.5 Billion by 2034, at a CAGR of 9.8% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Leidos, L3Harris Techn

Description: WALTHAM, Mass., October 28, 2025--From smartphones to autonomous cars to AI supercomputers, nearly every electronic innovation we use today depends on complicated structures at the atomic scale within silicon chips. As these chips increase in processing power and decrease in size, even the smallest fault can cause massive delays.

Description: Zacks showcases how its proven strategies and model portfolios continue to outperform, with PDD, Shopify and 3M among standout performers across portfolios.

Description: FRANKFURT, Germany, October 27, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of drug development during CPHI Frankfurt 2025 (October 28–30, booth #5.1A8, Hall 5.1). Leaders from across the organization will participate in a series of panel discussions highlighting industry trends, sustainability strategies and how collaboration can accelera

Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer put under the spotlight recently. Cramer discussed the company’s latest earnings, as he commented: “So what do we make of these numbers from Thermo Fisher Scientific, a company I’ve liked for so long? It’s a big life sciences company, reported better than expected […]

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: WALTHAM, Mass., October 23, 2025--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector, the industry’s first high-resolution accurate mass (HRAM) Orbitrap system designed specifically for environmental and food safety laboratories. The new system addresses urgent global challenges around food and water quality testing in the face of persistent contaminants, such as per- and polyfluoroalkyl substances (PFAS),

Description: Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue growth and a raised full-year outlook. Investors are watching how recent partnerships and innovation continue to fuel that momentum. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher’s upbeat quarter arrives on the back of some exciting moves, from launching cutting-edge microarray technology to rolling out new AI collaborations in drug development...

Description: Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per share was 5.3% above analysts’ consensus estimates.

Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy right now. On October 20, Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO), without assigning a price target. The rating update followed Thermo Fisher Scientific Inc.’s (NYSE:TMO) announcement on […]

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: Thermo Fisher Scientific Inc (TMO) reports robust financial performance with a 5% revenue increase and upwardly revised 2025 guidance, despite facing headwinds in certain sectors.

Description: Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 0.6% and the Health

Description: Pre-Market Futures Flat at This Hour.

Description: Thermo Fisher Scientific (TMO) raised its full-year outlook on Wednesday as the medical-device manuf

Description: Q3 earnings reports released yesterday afternoon did not quite have the positive sheen we've seen elsewhere this far into earnings season.

Description: While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Description: TMO delivers robust Q3 results, fueled by margin growth, new launches and AI-focused strategic initiatives.

Description: US equity futures were flat ahead of Wednesday's opening bell as traders looked ahead to earnings fr

Description: The main US stock measures were trending lower in Wednesday's premarket activity as President Donald

Description: Thermo Fisher (TMO) delivered earnings and revenue surprises of +5.27% and +1.99%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Investing.com -- Thermo Fisher Scientific Inc. (NYSE:TMO) reported third-quarter results that exceeded analyst expectations, with adjusted earnings per share and revenue both surpassing consensus estimates. Shares of the scientific equipment maker rose 1.4% following the announcement.

Description: Thermo Fisher Scientific (TMO) reported fiscal Q3 adjusted earnings Wednesday of $5.79 per diluted s

Description: WALTHAM, Mass. AP) — Thermo Fisher Scientific Inc. TMO) on Wednesday reported third-quarter earnings of $1.62 billion.

Description: Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per share was 5.3% above analysts’ consensus estimates.

Description: WALTHAM, Mass., October 22, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 27, 2025.

Description: The U.S. government shutdown continues, but investors won't be completely starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: WILMINGTON, N.C., October 21, 2025--Thermo Fisher Scientific Launches Innovative Carbon Calculator to Drive Greener Clinical Trials

Description: The bioseparation systems market offers growth opportunities driven by increasing biopharmaceutical demands, particularly in emerging markets like Japan and the Pacific Rim. Key methods like chromatography play a crucial role in drug development. Major players include Thermo Fisher and Sartorius. Separation Systems for Commercial Biotechnology Market Separation Systems for Commercial Biotechnology Market Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Separation Systems for Commercial Biotechnolo

Description: The U.S. government shutdown continues, but investors won't be completely starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.

Description: Life sciences company Thermo Fisher (NYSE:TMO) will be announcing earnings results this Wednesday morning. Here’s what investors should know.

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.

Description: As investors enters shutdown week three, a US-China trade war, credit gesticulation, and an incoming oil glut are weighing on the market.

Description: The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.

Description: Thermo Fisher Scientific recently announced a collaboration with OpenAI to integrate advanced artificial intelligence into its Accelerator Drug Development solution, aiming to enhance the speed and success rate of drug development for its customers. This partnership highlights the growing role of AI in accelerating clinical trials and streamlining therapeutic discovery, positioning Thermo Fisher Scientific at the forefront of digital transformation in the life sciences industry. We'll...

Description: Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Description: Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.